Completed PHASE2 INTERVENTIONAL 2-arm NCT00940797

Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients (CLAMP) (DMMETclamp)

Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients by Glucose CLAMP Technique

Sponsor: Laboratorios Silanes S.A. de C.V.

Updated 5 times since 2017 Last updated: Jul 15, 2009 Started: Jul 31, 2008 Primary completion: Feb 28, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Diabetes Type 2 and is currently completed. Laboratorios Silanes S.A. de C.V. leads this study, which shows 5 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jul 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Laboratorios Silanes S.A. de C.V.

Data source: Laboratorios Silanes S.A. de C.V.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guadalajara, Mexico